bird-flu-stocks-logo
birdflustocks.com
bird flu stocks
birdflustocks.com » bird flu stocks  » 
bird flu stocks
Vir Biotechnology: VIR-2482 phase 2 study data coming soon?
By admin | |
Official Title: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study to
Sanofi: mRNA seasonal influenza vaccine development to be restarted with advanced technology
By admin | |
https://www.fiercebiotech.com/biotech/first-gen-mrna-flu-vaccines-wont-win-sanofi-execs-admit-they-retool-strategy
SAB Biotherapeutics: SAB-176 Phase 2a study completed, FDA has granted Fast Track designation
By admin | |
Johnson & Johnson: Janssen to Discontinue Pimodivir Influenza Development Program
By admin | |
https://www.americanpharmaceuticalreview.com/1315-News/567852-Janssen-to-Discontinue-Pimodivir-Influenza-Development-Program/
1 2 3 4